Mechanism of the hypoxia inducible factor 1/hypoxic response element pathway in rat myocardial ischemia/diazoxide post‑conditioning

Li,Jin; Zhou,Wenjing; Chen,Wei; Wang,Haiying; Zhang,Yu; Yu,Tian

doi:10.3892/mmr.2020.10966

Mechanism of the hypoxia inducible factor 1/hypoxic response element pathway in rat myocardial ischemia/diazoxide post‑conditioning

Authors:
- Jin Li
- Wenjing Zhou
- Wei Chen
- Haiying Wang
- Yu Zhang
- Tian Yu
View Affiliations

Affiliations: Department of Anesthesiology, Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China
Published online on: January 28, 2020 https://doi.org/10.3892/mmr.2020.10966
Pages: 1527-1536
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ischemic post‑conditioning (IPO) and diazoxide post‑conditioning (DPO) has been proven to reduce myocardial ischemia reperfusion injury (MIRI); however, the mechanisms of IPO/DPO are still not clear. The present study aimed to investigate whether mitochondrial ATP‑sensitive potassium channels (mitoKATP) channels are activated by IPO/DPO, which may further activate the hypoxia inducible factor 1/hypoxic response element (HIF‑1/HRE) pathway to mitigate MIRI. Using a Langendorff perfusion device, healthy male (250‑300 g) Sprague Dawley rat hearts were randomly divided into the following groups. Group N was aerobically perfused with K‑H solution for 120 min. Group ischaemia/reperfusion (I/R) was aerobically perfused for 20 min, then subjected to 40 min hypoxia plus 60 min reperfusion. Group IPO was treated like the I/R group, but with 10 sec of hypoxia plus 10 sec of reperfusion for six rounds before reperfusion. Group DPO was exposed to 50 µM diazoxide for 5 min before reperfusion and otherwise treated the same as group I/R. In groups IPO+5‑hydroxydecanoic acid (5HD), DPO+5HD and I/R+5HD, exposure to 100 µM 5HD (a mitoKATP channel specific blocker) for 5 min before reperfusion as described for groups IPO, DPO and I/R, respectively. In groups IPO+2‑methoxyestradiol (2ME2), DPO+2ME2 and I/R+2ME2, exposure to 2 µM 2ME2 (a HIF‑1α specific blocker) for 10 min before reperfusion as described for groups IPO, DPO and I/R respectively. Cardiac hemodynamics, myocardial injury and the expression of HIF‑1/HRE pathway [HIF‑1α, heme oxygenase (HO‑1), inducible nitric oxide synthase (iNOS) and vascular endothelial growth factor (VEGF)] were detected in each group. The infarct size and mitochondrial Flameng scores of groups IPO/DPO were significantly decreased compared with the I/R group (P<0.05), but the myocardial protective effects of IPO/DPO could be eliminated by 5HD or 2ME2 (P<0.05). In addition, IPO/DPO could increase the mRNA expression of HIF‑1α and the downstream factors of the HIF‑1/HRE pathway (the mRNA and protein expression of HO‑1, iNOS and VEGF; P<0.05). However, the myocardial protective effects and the activation the HIF‑1/HRE pathway mediated by IPO/DPO could be eliminated by 5HD or 2ME2 (P<0.05). Therefore, the activation of the HIF‑1/HRE pathway by opening mitoKATP channels may work with the mechanism of IPO/DPO in reducing MIRI.

View Figures

View References

1	Jennings RB, Sommers HM, Smyth GA, Flack HA and Linn H: Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol. 70:68–78. 1960.PubMed/NCBI
2	Hausenloy DJ, Boston-Griffiths E and Yellon DM: Cardioprotection during cardiac surgery. Cardiovasc Res. 94:253–265. 2012. View Article : Google Scholar : PubMed/NCBI
3	Frankenreiter S, Groneberg D, Kuret A, Krieg T, Ruth P, Friebe A and Lukowski R: Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase. Cardiovasc Res. 114:822–829. 2018. View Article : Google Scholar : PubMed/NCBI
4	Pachauri P, Garabadu D, Goyal A and Upadhyay PK: Angiotensin (1–7) facilitates cardioprotection of ischemic preconditioning on ischemia-reperfusion-challenged rat heart. Mol Cell Biochem. 430:99–113. 2017. View Article : Google Scholar : PubMed/NCBI
5	Hao YL, Fang HC, Zhao HL, Li XL, Luo Y, Wu BQ, Fu MJ, Liu W, Liang JJ and Chen XH: The role of microRNA-1 targeting of MAPK3 in myocardial ischemia-reperfusion injury in rats undergoing sevoflurane preconditioning via the PI3K/Akt pathway. Am J Physiol Cell Physiol. 315:C380–C388. 2018. View Article : Google Scholar : PubMed/NCBI
6	Zhang FW, Tong J, Yan YS, Chen QQ and Zhao XP: ω-3 polyunsaturated fatty acid postconditioning protects the isolated perfused rat heart from ischemia-reperfusion injury. Cardiorenal Med. 8:173–182. 2018. View Article : Google Scholar : PubMed/NCBI
7	Yang YH, Zhang Y, Chen W, Wang Y, Cao S, Yu T and Wang H: Pinacidil-postconditioning is equivalent to ischemic postconditioning in defeating cardiac ischemia-reperfusion injury in rat. Eur J Pharmacol. 780:26–32. 2016. View Article : Google Scholar : PubMed/NCBI
8	Testai L, Marino A, Piano I, Brancaleone V, Tomita K, Di Cesare Mannelli L, Martelli A, Citi V, Breschi MC, Levi R, et al: The novel H₂S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoK_ATP channels and reduction of oxidative stress. Pharmacol Res. 113:290–299. 2016. View Article : Google Scholar : PubMed/NCBI
9	Hnatiuk AP, Ong SG, Olea FD, Locatelli P, Riegler J, Lee WH, Jen CH, De Lorenzi A, Giménez CS, Laguens R, et al: Allogeneic mesenchymal stromal cells overexpressing mutant human hypoxia-inducible factor 1-α (HIF1-α) in an ovine model of acute myocardial infarction. J Am Heart Assoc. 5:e0037142016. View Article : Google Scholar : PubMed/NCBI
10	Zhao HX, Wang XL, Wang YH, Wu Y, Li XY, Lv XP, Zhao ZQ, Zhao RR and Liu HR: Attenuation of myocardial injury by postconditioning: Role of hypoxia inducible factor-1alpha. Basic Res Cardiol. 105:109–118. 2010. View Article : Google Scholar : PubMed/NCBI
11	Si J, Wang N, Wang H, Xie J, Yang J, Yi H, Shi Z, Ma J, Wang W, Yang L, et al: HIF-1α signaling activation by post-ischemia treatment with astragaloside IV attenuates myocardial ischemia-reperfusion injury. PLoS One. 9:e1078322014. View Article : Google Scholar : PubMed/NCBI
12	Jin C, Wu J, Watanabe M, Okada T and Iesaki T: Mitochondrial K⁺ channels are involved in ischemic postconditioning in rat hearts. J Physiol Sci. 62:325–332. 2012. View Article : Google Scholar : PubMed/NCBI
13	Penna C, Perrelli MG, Tullio F, Angotti C, Camporeale A, Poli V and Pagliaro P: Diazoxide postconditioning induces mitochondrial protein S-nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: No role for SAFE. Basic Res Cardiol. 108:3712013. View Article : Google Scholar : PubMed/NCBI
14	Flagg TP, Enkvetchakul D, Koster JC and Nichols CG: Muscle KATP channels: Recent insights to energy sensing and myoprotection. Physiol Rev. 90:799–829. 2010. View Article : Google Scholar : PubMed/NCBI
15	Olejnickova V, Novakova M and Provaznik I: Isolated heart models: Cardiovascular system studies and technological advances. Med Biol Eng Comput. 53:669–678. 2015. View Article : Google Scholar : PubMed/NCBI
16	Flameng W, Borgers M, Daenen W and Stalpaert G: Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man. J Thorac Cardiovasc Surg. 79:413–424. 1980. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Yang L, Xie P, Wu J, Yu J, Yu T, Wang H, Wang J, Xia Z and Zheng H: Sevoflurane postconditioning improves myocardial mitochondrial respiratory function and reduces myocardial ischemia-reperfusion injury by up-regulating HIF-1. Am J Transl Res. 8:4415–4424. 2016.PubMed/NCBI
19	Eckle T, Kohler D, Lehmann R, El KK and Eltzschig HK: Hypoxia-inducible factor-1 is central to cardioprotection: A new paradigm for ischemic preconditioning. Circulation. 118:166–175. 2008. View Article : Google Scholar : PubMed/NCBI
20	Ong SG and Hausenloy DJ: Hypoxia-inducible factor as a therapeutic target for cardioprotection. Pharmacol Ther. 136:69–81. 2012. View Article : Google Scholar : PubMed/NCBI
21	Xie J, Liao Y, Yang L, Wu J, Liu C, Xuan W, Li M, Zhang L, Liu Y, Wu P and Bin J: Ultrasound molecular imaging of angiogenesis induced by mutant forms of hypoxia-inducible factor-1α. Cardiovasc Res. 92:256–266. 2011. View Article : Google Scholar : PubMed/NCBI
22	Tian YM, Mole DR, Ratcliffe PJ and Gleadle JM: Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation. Biochem J. 397:179–186. 2006. View Article : Google Scholar : PubMed/NCBI
23	Tekin D, Dursun AD and Xi L: Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacol Sin. 31:1085–1094. 2010. View Article : Google Scholar : PubMed/NCBI
24	Zimna A and Kurpisz M: Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: Applications and therapies. Biomed Res Int. 2015:5494122015. View Article : Google Scholar : PubMed/NCBI
25	Poynter JA, Manukyan MC, Wang Y, Brewster BD, Herrmann JL, Weil BR, Abarbanell AM and Meldrum DR: Systemic pretreatment with dimethyloxalylglycine increases myocardial HIF-1α and VEGF production and improves functional recovery after acute ischemia/reperfusion. Surgery. 150:278–283. 2011. View Article : Google Scholar : PubMed/NCBI
26	Li X, Zhao H, Wu Y, Zhang S, Zhao X, Zhang Y, Wang J, Wang J and Liu H: Up-regulation of hypoxia-inducible factor-1alpha enhanced the cardioprotective effects of ischemic postconditioning in hyperlipidemic rats. Acta Biochim Biophys Sin (Shanghai). 46:112–118. 2014. View Article : Google Scholar : PubMed/NCBI
27	Zhao H, Wang Y, Wu Y, Li X, Yang G, Ma X, Zhao R and Liu H: Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1alpha upregulation. Acta Biochim Biophys Sin (Shanghai). 41:745–753. 2009. View Article : Google Scholar : PubMed/NCBI
28	Granfeldt A, Jiang R, Wang NP, Mykytenko J, Eldaif S, Deneve J, Zhao ZQ, Guyton RA, Tønnesen E and Vinten-Johansen J: Neutrophil inhibition contributes to cardioprotection by postconditioning. Acta Anaesthesiol Scand. 56:48–56. 2012. View Article : Google Scholar : PubMed/NCBI
29	Wang ZH, Liu JL, Wu L, Yu Z and Yang HT: Concentration-dependent wrestling between detrimental and protective effects of H₂O₂ during myocardial ischemia/reperfusion. Cell Death Dis. 5:e12972014. View Article : Google Scholar : PubMed/NCBI
30	Ferdinandy P, Schulz R and Baxter GF: Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 59:418–458. 2007. View Article : Google Scholar : PubMed/NCBI
31	Ichinomiya T, Cho S, Higashijima U, Matsumoto S, Maekawa T and Sumikawa K: High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: Role of mitochondrial KATP channels. Cardiovasc Diabetol. 11:282012. View Article : Google Scholar : PubMed/NCBI
32	Andrukhiv A, Costa AD, West IC and Garlid KD: Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol. 291:H2067–H2074. 2006. View Article : Google Scholar : PubMed/NCBI
33	Koshikawa N, Hayashi J, Nakagawara A and Takenaga K: Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway. J Biol Chem. 284:33185–33194. 2009. View Article : Google Scholar : PubMed/NCBI